Boston Lifescience Private Limited
About Boston Lifescience Private Limited
Data last updated:
Boston Lifescience Private Limited is a private limited company based in Delhi, India. It was incorporated on 05 July 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2024PTC433819.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajinder Pal Singh and Sunita Arora.
Its last annual general meeting (AGM) was held on 30 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Desk – 45 Cw – 59, Sanjay Gandhi Transport Nagar, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.72 Cr. For the same year it recorded a net loss of ₹15.76 Lakh (net margin -9.2%) and EBITDA of -₹15.76 Lakh (EBITDA margin -9.2%).
Company details
Contact details
Boston Lifescience Private Limited's registered office is in Delhi, Delhi.
- Registered AddressDesk – 45 Cw – 59, Sanjay Gandhi Transport Nagar, Delhi, India – 110042
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Boston Lifescience Private Limited
FY 2025 filings availableBoston Lifescience Private Limited reported revenue of ₹1.72 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹15.76 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹15.76 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -9.2% |
| Net Profit Margin | -9.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Boston Lifescience Private Limited, buy the company report.
Board of directors of Boston Lifescience Private Limited
Boston Lifescience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajinder Pal Singh Also directs: Boston Top Pharma LLP | Director | 05 Jul 2024 | 2 Years 3 Months | Current |
| Sunita Arora Also directs: Boston Top Pharma LLP | Director | 05 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Boston Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Miyota Healthcare Private Limited | ₹1.72 Cr (FY 2024) | -21.0% | Hooghly, West Bengal, India | |||
| Gids Medi Solutions Private Limited | ₹1.72 Cr (FY 2025) | 5.0% | Chengannur, Kerala, India | |||
| Cicerone Healthcare Private Limited | ₹1.72 Cr (FY 2019) | 27.0% | Kollam, Kerala, India | |||
| Bhutada & Udgire Cardiac Care Private Limited | ₹1.72 Cr (FY 2024) | 31.0% | Aurangabad, Maharashtra, India | |||
| Udit Healthcare Private Limited | ₹1.72 Cr (FY 2020) | 3.0% | Ahmedabad, Gujarat, India | |||
| Boston Lifescience Private Limitedthis company | ₹1.72 Cr (FY 2025) | -₹15.76 Lakh | -9.2% | Delhi, India | ||
| Hospi Medix Private Limited | ₹1.72 Cr (FY 2025) | 70.0% | Bangalore, Karnataka, India | |||
| Raghav Sai Pharmaceuticals Pvt.Ltd. | ₹1.72 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| Indisun Healthcare Private Limited | ₹1.72 Cr (FY 2025) | 253.0% | Lucknow, Uttar Pradesh, India | |||
| Morita Dental India Private Limited | ₹1.72 Cr (FY 2025) | New Delhi, Delhi, India | ||||
| Suprv Innovations Private Limited | ₹1.71 Cr (FY 2025) | 2806.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Boston Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Boston Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Boston Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Boston Lifescience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Boston Lifescience Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Rajinder Pal Singh was appointed as Director on 05 Jul 2024.
Frequently asked questions
Boston Lifescience is an active private limited company based in Delhi, India. It was incorporated on 05 July 2024 (2+ years old) and is registered under CIN U47721DL2024PTC433819.
Boston Lifescience has 2 current directors:
- Rajinder Pal Singh - Director
- Sunita Arora - Director
The latest financial statements of Boston Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Boston Lifescience is U47721DL2024PTC433819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Boston Lifescience was incorporated on 05 July 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Boston Lifescience by revenue are Miyota Healthcare Private Limited, Gids Medi Solutions Private Limited, Cicerone Healthcare Private Limited, Bhutada & Udgire Cardiac Care Private Limited, Udit Healthcare Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).
Rajinder Pal Singh was appointed as Director on 05 Jul 2024. Sunita Arora was appointed as Director on 05 Jul 2024.
The registered office of Boston Lifescience is at Desk – 45 Cw – 59, Sanjay Gandhi Transport Nagar, Delhi, India – 110042.
Boston Lifescience can be reached at its registered office: Desk – 45 Cw – 59, Sanjay Gandhi Transport Nagar, Delhi, India – 110042.
Boston Lifescience is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.